112 related articles for article (PubMed ID: 21801234)
21. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
22. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
[TBL] [Abstract][Full Text] [Related]
24. A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Hebb J; Assouline S; Rousseau C; Desjardins P; Caplan S; Egorin MJ; Amrein L; Aloyz R; Panasci L
Cancer Chemother Pharmacol; 2011 Sep; 68(3):643-51. PubMed ID: 21120481
[TBL] [Abstract][Full Text] [Related]
25. The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma.
Hangül C; Yücel OK; Akkaya B; Ündar L; Berker Karaüzüm S
Turk J Haematol; 2019 May; 36(2):124-125. PubMed ID: 29923494
[No Abstract] [Full Text] [Related]
26. [Collision tumor of small lymphocytic lymphoma and histiocytic sarcoma: report of a case].
Gao LX; Liu G; Yang GZ; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):775. PubMed ID: 20079020
[No Abstract] [Full Text] [Related]
27. Chemoimmunotherapy for chronic lymphocytic leukemia.
Spehn J; Mühlbauer B
N Engl J Med; 2014 Jun; 370(24):2348. PubMed ID: 24918384
[No Abstract] [Full Text] [Related]
28. Simultaneous occurrence of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia.
Bueno J; Irriguible MD; Palacio C
Haematologica; 2002 Apr; 87(4):EIM11. PubMed ID: 11940498
[No Abstract] [Full Text] [Related]
29. Obinutuzumab looks impressive in CLL.
Cancer Discov; 2014 Apr; 4(4):OF5. PubMed ID: 24706674
[No Abstract] [Full Text] [Related]
30. Chemoimmunotherapy for chronic lymphocytic leukemia. Author reply.
Goede V; Fischer K; Hallek M
N Engl J Med; 2014 Jun; 370(24):2348-9. PubMed ID: 24918383
[No Abstract] [Full Text] [Related]
31. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
32. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
Binet JL
Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
[No Abstract] [Full Text] [Related]
33. Twice-daily pill could treat leukemia.
Printz C
Cancer; 2014 Aug; 120(15):2225. PubMed ID: 25047250
[No Abstract] [Full Text] [Related]
34. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
35. Why R-CHOP for first line treatment of chronic lymphocytic leukemia?
Smolej L
Int J Lab Hematol; 2007 Dec; 29(6):478-9; author reply 479. PubMed ID: 17988306
[No Abstract] [Full Text] [Related]
36. Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia.
Binet JL; Mentz F; Leblond V; Merle-Beral H
Leukemia; 1995 Dec; 9(12):2159-61. PubMed ID: 8609738
[No Abstract] [Full Text] [Related]
37. Chronic lymphocytic leukemia masquerading as uveitis.
Gupta G; Larson RA; Jampol LM
Retina; 2007; 27(9):1311-2. PubMed ID: 18046244
[No Abstract] [Full Text] [Related]
38. [Acute myelogenous leukemia (M4) occurring during chronic lymphocytic leukemia].
Morita K; Mizuno T; Tanaka I; Suzuki H; Tanaka I; Miwa H; Nishikawa M; Kita K; Shiku H
Rinsho Ketsueki; 1997 Nov; 38(11):1212-7. PubMed ID: 9423340
[TBL] [Abstract][Full Text] [Related]
39. Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.
D'Auria F; Guariglia R; Villani O; Mansueto G; Grieco V; Zonno A; Bianchino G; Di Giovannantonio L; Vita G; Musto P
Clin Ther; 2010 Oct; 32(11):1911-6. PubMed ID: 21095486
[TBL] [Abstract][Full Text] [Related]
40. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
